Connect to other sites within the UBM Medica Network
The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.
Lead with Weight Loss, Say New Endo Society Guidelines
The new guidelines signal a shift toward aggressive treatment for obesity as a primary disease and following with treatment for comorbidites that do not respond to weight loss.
Two-Year Results Support Use of Canagliflozin in the Elderly
Long-term use of this SGLT2 inhibitor revealed sustained clinical benefits in older patients with diabetes and most AEs reported were mild.
5 Things You Need to Know About SGLT2-I Use in the Elderly
SGLT2 inhibitors perform well in older patients and cause minimal hypoglycemia. But caution is advised and here are 5 reasons why.
Top 10 Endocrinology Apps
Endo Tools, Endo Pubs, Glooko--just a few of the mobile apps described here, all designed specifically for the clinical endocrinologist.
Truths About HbA1c
In the international diabetes community the topic of hemoglobin A1c (HbA1c) continues to generate controversy for a number of reasons.
Diabetes and GI Woes
Three-quarters of persons with diabetes will experience significant gastrointestinal symptoms. What underlies the evolution of these GI ailments?
Statins Urged for Diabetes to Curb Heart Disease
Recommendations from the American Diabetes Association also suggest a less stringent diastolic blood pressure target, all in keeping with recent changes in cardiovascular risk management guidelines.
Man With Newly Diagnosed Type 2 Diabetes: What HbA1c Goal—And How to Get There?
The patient, an active 49-year-old man, had an HbA1c of 8.6 after diabetes was first diagnosed. It’s now 7.6 with metformin and lifestyle measures. Is the current A1c goal adequate, or should you treat more aggressively?
Challenging Case: A Patient With Hypoglycemia and High HbA1c
Hypoglycemia in type 2 diabetes patients can be the result of insulin or sulfonylureas.
Podcast: Bariatric Surgery Bests Medical Therapy Alone in Obese Patients with Diabetes
Bariatric surgery nearly cures type 2 diabetes—at least that’s what results of a new study, presented at the recent ACC meeting, seem to imply.
Podcast: Incretins for Type 2 Diabetes Mellitus (Part 2)
In his second podcast, Dr Louis Kuritzky discusses the classes of incretin-based therapies now available for patients with type 2 diabetes mellitus.
By clicking Accept, you agree to become a member of the UBM Medica Community.